DEFEROXAMINE MESYLATE — all Canadian products
7 DINs
3 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is DEFEROXAMINE MESYLATE, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02247022 | DEFEROXAMINE MESYLATE FOR INJECTION | PFIZER CANADA ULC | Powder For Solution | Intramuscular; Subcutaneous; Intraperitoneal; Intravenous | DEFEROXAMINE MESYLATE 2 G | Marketed | |
| 02241600 | DEFEROXAMINE MESYLATE FOR INJECTION | PFIZER CANADA ULC | Powder For Solution | Intramuscular; Intraperitoneal; Subcutaneous; Intravenous | DEFEROXAMINE MESYLATE 500 MG | Marketed | |
| 01981242 | DESFERAL | MITEM PHARMA | Powder For Solution | Intramuscular; Intravenous; Subcutaneous; Intraperitoneal | DEFEROXAMINE MESYLATE 500 MG | Marketed | |
| 02261820 | DEFEROXAMINE MESYLATE FOR INJECTION | SANDOZ CANADA INCORPORATED | Powder For Solution | Intravenous; Subcutaneous; Intramuscular; Intraperitoneal | DEFEROXAMINE MESYLATE 2 G | Cancelled Pre Market | |
| 01981250 | DESFERAL 2G | NOVARTIS PHARMACEUTICALS CANADA INC | Powder For Solution | Intraperitoneal; Intravenous; Subcutaneous; Intramuscular | DEFEROXAMINE MESYLATE 2 G | Cancelled Post Market | |
| 02242055 | PMS-DEFEROXAMINE | PHARMASCIENCE INC | Powder For Solution | Subcutaneous; Intravenous; Intramuscular; Intraperitoneal | DEFEROXAMINE MESYLATE 500 MG | Cancelled Post Market | |
| 02243450 | PMS-DEFEROXAMINE | PHARMASCIENCE INC | Powder For Solution | Intramuscular; Intraperitoneal; Intravenous; Subcutaneous | DEFEROXAMINE MESYLATE 2 G | Cancelled Post Market |
Browse other molecules: